2022.v1 NCCN临床实践指南：免疫治疗毒性管理.pdfVIP

® NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) Management of Immunotherapy-Related Toxicities Version 1.2022 — February 28, 2022 NCCN.org Continue ® ® ® Version 1.2022, 02/28/22 © 2022 National Comprehensive Cancer Network (NCCN ), All rights reserved. NCCN Guidelines and this illustration may not be reproduced in any form without the express written permission of NCCN. Printed by Simon Zenith on 3/1/2022 11:16:53 PM. For personal use only. Not approved for distribution. Copyright © 2022 National Comprehensive Cancer Network, Inc., All Rights Reserved. NCCN Guidelines Version 1.2022 NCCN Guidelines Index Table of Contents Management of Immunotherapy-Related Toxicities Discussion *John A. Thompson, MD/Chair † ‡ Yaron Gesthalter, MD X Anthony J. Olszanski, MD, RPh † Fred Hutchinson Cancer Research Center/ UCSF Helen Diller Family Fox Chase Cancer Center Seattle Cancer Care Alliance Comprehensive Cancer Center Olalekan Oluwole, MD ‡ *Bryan J. Schneider, MD/Vice-Chair †